FinnCap Reaffirms “Corporate” Rating for Tristel (TSTL)

Tristel (LON:TSTL)‘s stock had its “corporate” rating restated by stock analysts at FinnCap in a research report issued to clients and investors on Monday, March 26th. They currently have a GBX 280 ($4.01) target price on the stock.

Shares of LON TSTL remained flat at $GBX 280 ($4.01) during midday trading on Monday. 25,368 shares of the company were exchanged, compared to its average volume of 35,859. Tristel has a twelve month low of GBX 175.56 ($2.51) and a twelve month high of GBX 326.01 ($4.67).

TRADEMARK VIOLATION WARNING: “FinnCap Reaffirms “Corporate” Rating for Tristel (TSTL)” was originally posted by The Ledger Gazette and is owned by of The Ledger Gazette. If you are viewing this article on another publication, it was illegally stolen and reposted in violation of United States & international trademark and copyright legislation. The original version of this article can be viewed at

About Tristel

Tristel plc develops, manufactures, and markets infection control, contamination control, and hygiene products in the United Kingdom, Germany, and internationally. It offers hospital infection prevention and control products under the Tristel brand; contamination control products for pharmaceutical and personal care industries under the Crystel brand; and animal health infection prevention and control products under the Anistel brand.

Receive News & Ratings for Tristel Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tristel and related companies with's FREE daily email newsletter.

Leave a Reply